Jailendra Singh
Stock Analyst at Truist Securities
(0.84)
# 4,012
Out of 5,182 analysts
196
Total ratings
25.45%
Success rate
-26.05%
Average return
Main Sectors:
Stocks Rated by Jailendra Singh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DOCS Doximity | Downgrades: Hold | $37 → $29 | $24.66 | +17.60% | 11 | Apr 20, 2026 | |
| PHR Phreesia | Downgrades: Hold | $24 → $11 | $9.62 | +14.35% | 8 | Mar 31, 2026 | |
| ASTH Astrana Health | Maintains: Buy | $37 → $38 | $34.01 | +11.73% | 6 | Mar 13, 2026 | |
| VEEV Veeva Systems | Reiterates: Buy | $275 → $262 | $160.45 | +63.29% | 8 | Mar 5, 2026 | |
| PGNY Progyny | Maintains: Buy | $34 → $28 | $18.41 | +52.09% | 11 | Mar 2, 2026 | |
| PRVA Privia Health Group | Maintains: Buy | $31 → $33 | $24.41 | +35.19% | 9 | Mar 2, 2026 | |
| EVH Evolent Health | Maintains: Buy | $10 → $6 | $3.47 | +72.91% | 9 | Feb 26, 2026 | |
| HIMS Hims & Hers Health | Reiterates: Hold | $37 → $18 | $29.39 | -38.75% | 12 | Feb 24, 2026 | |
| IQV IQVIA Holdings | Maintains: Buy | $290 → $245 | $163.84 | +49.54% | 19 | Feb 19, 2026 | |
| WAY Waystar Holding | Maintains: Buy | $51 → $38 | $25.70 | +47.86% | 4 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $555 → $539 | $421.37 | +27.92% | 7 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $52 | $45.23 | +14.97% | 1 | Jan 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $231 → $222 | $103.21 | +115.10% | 11 | Jan 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $12 → $22 | $10.60 | +107.55% | 1 | Jan 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $48 | $45.03 | +6.60% | 1 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $10 → $9 | $5.85 | +53.85% | 16 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $6.5 → $5.5 | $2.28 | +141.23% | 12 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $12 → $7.5 | $6.14 | +22.15% | 7 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $14 | $10.25 | +36.59% | 1 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $160 → $163 | $25.32 | +541.79% | 8 | May 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $13 | $1.76 | +638.64% | 11 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $30 → $24 | $1.01 | +2,276.24% | 2 | Feb 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $14 → $4 | $0.92 | +335.78% | 4 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $58 | $202.34 | -71.34% | 2 | Feb 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $90 → $45 | $1.17 | +3,746.15% | 7 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $230 → $333 | $828.32 | -59.80% | 6 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $9 | $2.52 | +257.14% | 2 | May 19, 2021 |
Doximity
Apr 20, 2026
Downgrades: Hold
Price Target: $37 → $29
Current: $24.66
Upside: +17.60%
Phreesia
Mar 31, 2026
Downgrades: Hold
Price Target: $24 → $11
Current: $9.62
Upside: +14.35%
Astrana Health
Mar 13, 2026
Maintains: Buy
Price Target: $37 → $38
Current: $34.01
Upside: +11.73%
Veeva Systems
Mar 5, 2026
Reiterates: Buy
Price Target: $275 → $262
Current: $160.45
Upside: +63.29%
Progyny
Mar 2, 2026
Maintains: Buy
Price Target: $34 → $28
Current: $18.41
Upside: +52.09%
Privia Health Group
Mar 2, 2026
Maintains: Buy
Price Target: $31 → $33
Current: $24.41
Upside: +35.19%
Evolent Health
Feb 26, 2026
Maintains: Buy
Price Target: $10 → $6
Current: $3.47
Upside: +72.91%
Hims & Hers Health
Feb 24, 2026
Reiterates: Hold
Price Target: $37 → $18
Current: $29.39
Upside: -38.75%
IQVIA Holdings
Feb 19, 2026
Maintains: Buy
Price Target: $290 → $245
Current: $163.84
Upside: +49.54%
Waystar Holding
Feb 18, 2026
Maintains: Buy
Price Target: $51 → $38
Current: $25.70
Upside: +47.86%
Feb 11, 2026
Maintains: Hold
Price Target: $555 → $539
Current: $421.37
Upside: +27.92%
Jan 12, 2026
Initiates: Buy
Price Target: $52
Current: $45.23
Upside: +14.97%
Jan 8, 2026
Downgrades: Hold
Price Target: $231 → $222
Current: $103.21
Upside: +115.10%
Jan 8, 2026
Upgrades: Buy
Price Target: $12 → $22
Current: $10.60
Upside: +107.55%
Jun 16, 2025
Initiates: Buy
Price Target: $48
Current: $45.03
Upside: +6.60%
May 27, 2025
Maintains: Hold
Price Target: $10 → $9
Current: $5.85
Upside: +53.85%
Apr 10, 2025
Maintains: Hold
Price Target: $6.5 → $5.5
Current: $2.28
Upside: +141.23%
Apr 10, 2025
Maintains: Hold
Price Target: $12 → $7.5
Current: $6.14
Upside: +22.15%
Jul 2, 2024
Maintains: Buy
Price Target: $17 → $14
Current: $10.25
Upside: +36.59%
May 24, 2024
Maintains: Hold
Price Target: $160 → $163
Current: $25.32
Upside: +541.79%
May 4, 2022
Maintains: Neutral
Price Target: $16 → $13
Current: $1.76
Upside: +638.64%
Feb 24, 2022
Maintains: Neutral
Price Target: $30 → $24
Current: $1.01
Upside: +2,276.24%
Feb 8, 2022
Downgrades: Neutral
Price Target: $14 → $4
Current: $0.92
Upside: +335.78%
Feb 4, 2022
Maintains: Neutral
Price Target: $60 → $58
Current: $202.34
Upside: -71.34%
Jan 7, 2022
Downgrades: Underperform
Price Target: $90 → $45
Current: $1.17
Upside: +3,746.15%
Jan 7, 2022
Upgrades: Outperform
Price Target: $230 → $333
Current: $828.32
Upside: -59.80%
May 19, 2021
Maintains: Neutral
Price Target: $10 → $9
Current: $2.52
Upside: +257.14%